West Pharmaceutical Services Income After Taxes 2010-2024 | WST
West Pharmaceutical Services annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- West Pharmaceutical Services income after taxes for the quarter ending September 30, 2024 was $0.132B, a 16.18% decline year-over-year.
- West Pharmaceutical Services income after taxes for the twelve months ending September 30, 2024 was $0.484B, a 10.74% decline year-over-year.
- West Pharmaceutical Services annual income after taxes for 2023 was $0.576B, a 1.86% increase from 2022.
- West Pharmaceutical Services annual income after taxes for 2022 was $0.565B, a 11.92% decline from 2021.
- West Pharmaceutical Services annual income after taxes for 2021 was $0.642B, a 95.16% increase from 2020.
West Pharmaceutical Services Annual Income After Taxes
(Millions of US $) |
| 2023 |
$576 |
| 2022 |
$565 |
| 2021 |
$642 |
| 2020 |
$329 |
| 2019 |
$233 |
| 2018 |
$199 |
| 2017 |
$142 |
| 2016 |
$135 |
| 2015 |
$90 |
| 2014 |
$122 |
| 2013 |
$107 |
| 2012 |
$76 |
| 2011 |
$69 |
| 2010 |
$61 |
| 2009 |
$70 |
West Pharmaceutical Services Quarterly Income After Taxes
(Millions of US $) |
| 2024-09-30 |
$132 |
| 2024-06-30 |
$107 |
| 2024-03-31 |
$111 |
| 2023-12-31 |
$134 |
| 2023-09-30 |
$158 |
| 2023-06-30 |
$150 |
| 2023-03-31 |
$134 |
| 2022-12-31 |
$100 |
| 2022-09-30 |
$116 |
| 2022-06-30 |
$183 |
| 2022-03-31 |
$167 |
| 2021-12-31 |
$148 |
| 2021-09-30 |
$169 |
| 2021-06-30 |
$179 |
| 2021-03-31 |
$146 |
| 2020-12-31 |
$95 |
| 2020-09-30 |
$77 |
| 2020-06-30 |
$86 |
| 2020-03-31 |
$72 |
| 2019-12-31 |
$61 |
| 2019-09-30 |
$54 |
| 2019-06-30 |
$64 |
| 2019-03-31 |
$54 |
| 2018-12-31 |
$51 |
| 2018-09-30 |
$53 |
| 2018-06-30 |
$54 |
| 2018-03-31 |
$41 |
| 2017-12-31 |
$-3 |
| 2017-09-30 |
$49 |
| 2017-06-30 |
$38 |
| 2017-03-31 |
$57 |
| 2016-12-31 |
$37 |
| 2016-09-30 |
$35 |
| 2016-06-30 |
$43 |
| 2016-03-31 |
$21 |
| 2015-12-31 |
$31 |
| 2015-09-30 |
$-0 |
| 2015-06-30 |
$27 |
| 2015-03-31 |
$32 |
| 2014-12-31 |
$30 |
| 2014-09-30 |
$30 |
| 2014-06-30 |
$36 |
| 2014-03-31 |
$26 |
| 2013-12-31 |
$23 |
| 2013-09-30 |
$25 |
| 2013-06-30 |
$29 |
| 2013-03-31 |
$31 |
| 2012-12-31 |
$21 |
| 2012-09-30 |
$13 |
| 2012-06-30 |
$14 |
| 2012-03-31 |
$28 |
| 2011-12-31 |
$17 |
| 2011-09-30 |
$15 |
| 2011-06-30 |
$18 |
| 2011-03-31 |
$18 |
| 2010-12-31 |
$5 |
| 2010-09-30 |
$17 |
| 2010-06-30 |
$20 |
| 2010-03-31 |
$19 |
| 2009-12-31 |
$19 |
| 2009-09-30 |
$16 |
| 2009-06-30 |
$19 |
| 2009-03-31 |
$15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$24.592B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
